Phase II Study of Nab-Paclitaxel in Refractory Small Bowel Adenocarcinoma and CpG Island Methylator Phenotype (CIMP)-high Colorectal Cancer
Annals of Oncology- United Kingdom
doi 10.1093/annonc/mdy221
Full Text
Abstract
Available in
Date
March 1, 2019
Authors
Publisher
Elsevier BV